- 16 November 2022
Using sugar chains as a ‘virus glue’ could help DNA origami structures become antiviral agents.
- 28 October 2022
Ongoing effort to create a reflection of life’s protein-making machinery could provide access to mirror molecules for diagnostics, therapeutics, and more.
- 25 October 2022
Spoke-like templates bend a linear chain of 24 porphyrins into a light-harvesting hoop.
- 14 October 2022
No presorting needed in 2-step process that turns multiple plastics into single products.
- 05 October 2022
Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless receive prize for their work on reactions that quickly link up molecules and their application in living cells.
- 16 November 2022
TESTIMONIALS“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Freelance Science Writer
Author Archives: benbaxter
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.